Tetra Discovery Partners   Report issue

For profit Phase 1 Phase 3
Founded: Grand Rapids MI United States (2010)
Status: Acquired by Shionogi (2020)

Organization Overview

First Clinical Trial
2015
NCT02648672
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Tetra Discovery Partners